Skip to main content

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca
Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Alcaraz Lopez, Carlos Jorge

Institutions of which they are part

Senior researcher
Rheumatology
Vall Hebron Institut de Recerca

Related news

The new therapeutic strategy aims at maintaining the efficacy of thalidomide while avoiding its main systemic adverse effects.

The event, held as part of World Lupus Day, incorporated the perspective of people living with the disease to address the challenges associated with lupus.

The global biopharmaceutical company UCB has acquired the data and clinical knowledge business of IMIDomics, a spin-off of the Vall d’Hebron Institute of Research (VHIR).

Related professionals

Carolina Vicente Tomas

Carolina Vicente Tomas

Predoctoral researcher
Pharmacokinetic Nanoparticles
Read more
Ignacio Vaz-Romero Trueba

Ignacio Vaz-Romero Trueba

Predoctoral researcher
Liver Diseases
Read more
Antonio González Pérez

Antonio González Pérez

Research assistant
Multidisciplinary Nursing Research Group
Read more
Nuria Molist Brunet

Nuria Molist Brunet

Postdoctoral researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.